Policy / Pricing Italy leads the way on child genetic disease diagnosis PharmaphorumA scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems.Policy / PricingRare DiseaseRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) Pharmaphorum A scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems. Policy / PricingRare DiseaseRead full story Post navigation Previous: Asahi Kasei acquires German company AicurisNext: Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy Related Stories Policy / Pricing Mid-cap biotechs join Trump’s latest round of drug pricing deals pharminent September 1, 2026 Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones pharminent August 27, 2026 Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026